This makes completely no sense when they are growing revenue/profits over 50% easily and have zero debt and zero chance of going broke and they have an absolute market monopoly for years to come in the EPP space!
CUV has one orphan drug with a very limited market. They have no other products. The market look ahead and sees the Scenesse monopoly ending in a few years. The patents will begin to expire soon. It is possible sales will fall to almost zero if better or cheaper alternatives are available. That is how the pharmaceutical industry works.
- Forums
- ASX - By Stock
- CUV
- Clinuvel compared to Imugene
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
1.49%
!
$10.61

Clinuvel compared to Imugene, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.61 |
Change
-0.160(1.49%) |
Mkt cap ! $533.8M |
Open | High | Low | Value | Volume |
$10.60 | $10.72 | $10.54 | $275.7K | 25.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 144 | $10.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.62 | 119 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 93 | 10.620 |
1 | 51 | 10.610 |
2 | 2049 | 10.600 |
3 | 205 | 10.590 |
4 | 739 | 10.580 |
Price($) | Vol. | No. |
---|---|---|
10.650 | 129 | 7 |
10.660 | 348 | 7 |
10.670 | 203 | 3 |
10.680 | 314 | 6 |
10.690 | 2334 | 5 |
Last trade - 12.51pm 16/07/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
WCE
WEST COAST SILVER LIMITED
Bruce Garlick, Executive Chairman
Bruce Garlick
Executive Chairman
SPONSORED BY The Market Online